Part of a comprehensive analysis of the Medicines Act 1975
All Parts in This Series
Overview of Key Provisions Governing Medical Advertisements under the Medicines Act
The Medicines Act establishes a comprehensive regulatory framework to govern advertisements related to medicinal products in Singapore. This framework is designed to protect public health by ensuring that advertisements are truthful, not misleading, and do not make unsubstantiated claims about the prevention, alleviation, or cure of diseases. The key provisions that achieve these objectives are found in Sections 49 to 53 of the Act.
"49.—(1) Subject to the following provisions of this section, in this Part “advertisement” includes every form of advertising... (4) In this Part— “medical advertisement” means an advertisement relating or likely to cause any person to believe that it relates to any medicinal product or any device...;" — Section 49, Medicines Act 1975
Section 49 defines the scope of what constitutes an "advertisement" and a "medical advertisement." This foundational provision ensures that all forms of advertising media—whether print, electronic, or audiovisual—are captured under the regulatory ambit, except for certain spoken words not embodied in recordings or broadcasts. The purpose of this broad definition is to prevent circumvention of the law through novel advertising channels and to maintain consistent standards across all media.
"50.—(1) Subject to the following provisions of this section, any person who issues or causes another person to issue a false or misleading advertisement relating to medicinal products of any description shall be guilty of an offence... (7) Any person guilty of an offence under this section shall be liable on conviction to a fine not exceeding $5,000 or to imprisonment for a term not exceeding 2 years or to both." — Section 50, Medicines Act 1975
Section 50 prohibits the issuance of false or misleading advertisements relating to medicinal products. This provision serves to protect consumers from deceptive marketing practices that could lead to misuse of medicines or false expectations about their efficacy. The imposition of criminal penalties, including fines and imprisonment, underscores the seriousness of such offences and acts as a deterrent against non-compliance.
"51.—(1) A person must not publish or cause to be published— (a) any medical advertisement which directly or indirectly claims, indicates or suggests that the article advertised will prevent, alleviate or cure any disease or condition specified in the First Schedule; or (b) any advertisement referring to any skill or service relating to the treatment of any disease or condition affecting the human body. (3) Any person who contravenes subsection (1) shall be guilty of an offence and shall be liable on conviction to a fine not exceeding $5,000 or to imprisonment for a term not exceeding 2 years or to both." — Section 51, Medicines Act 1975
Section 51 specifically prohibits advertisements that claim to prevent, alleviate, or cure diseases or conditions listed in the First Schedule of the Act. This restriction is critical because it prevents unverified or exaggerated claims about serious diseases, thereby safeguarding public health and maintaining trust in medicinal products. The provision also prohibits advertisements that refer to skills or services related to treating such diseases, which could mislead consumers about the qualifications or efficacy of providers.
"52.—(1) The Minister may by regulations prohibit any one or more of the following:... (2) Without affecting subsection (1), the Minister may by regulations impose any requirements that the Minister considers necessary or expedient with respect to any one or more of the following matters:..." — Section 52, Medicines Act 1975
Section 52 empowers the Minister to regulate advertisements through subsidiary legislation. This delegation allows for flexible and responsive regulation, enabling the Minister to impose prohibitions or requirements as necessary to address emerging issues or technologies in advertising. It ensures that the regulatory framework remains current and effective without requiring frequent amendments to the primary legislation.
"53.—(1) The licensing authority may serve on any person a notice requiring that person... to furnish to the licensing authority such number of copies as may be so specified of any advertisement relating to medicinal products... (2) Any person who without reasonable excuse fails to comply with any requirement imposed on that person by a notice under this section shall be guilty of an offence and shall be liable on conviction to a fine not exceeding $2,000." — Section 53, Medicines Act 1975
Section 53 grants the licensing authority the power to require copies of advertisements for inspection and monitoring. This provision facilitates enforcement by enabling authorities to verify compliance with the Act’s advertising standards. The penalty for non-compliance ensures that entities cannot evade regulatory scrutiny.
Definitions and Their Importance in Regulating Medical Advertisements
Precise definitions are essential for the effective application of the Medicines Act’s provisions on advertisements. Section 49 provides these definitions, clarifying the scope and nature of regulated advertisements and representations.
"49.—(1) Subject to the following provisions of this section, in this Part “advertisement” includes every form of advertising, whether in a publication, or by the display of any notice or signboard, or by means of any catalogue, price list, letter (whether circular or addressed to a particular person) or other documents, or by words inscribed on any article, or by the exhibition of a photograph or a cinematograph film, or by way of sound recording, sound broadcasting or television, or in any other way... (2) Despite subsection (1), in this Part “advertisement” does not include spoken words except— (a) words forming part of a sound recording or embodied in a soundtrack associated with a cinematograph film; and (b) words broadcast by way of sound broadcasting or television or transmitted to subscribers to a diffusion service. (4) In this Part— “medical advertisement” means an advertisement relating or likely to cause any person to believe that it relates to any medicinal product or any device, instrument, apparatus or contrivance used or represented to be used for a medicinal purpose; “representation” means any statement or undertaking (whether constituting a condition or a warranty or not) which consists of spoken words other than words falling within subsection (2)(a) or (b), and any reference to making a representation is to be construed accordingly." — Section 49, Medicines Act 1975
The broad definition of "advertisement" ensures that all relevant promotional activities are regulated, preventing loopholes where certain media or formats might escape oversight. Excluding certain spoken words from the definition avoids overreach into casual or incidental speech, focusing regulatory efforts on deliberate advertising content. The definition of "medical advertisement" is tailored to capture advertisements that relate to medicinal products or devices, ensuring that claims about health-related products are scrutinized. The term "representation" covers spoken statements not otherwise excluded, ensuring that verbal claims are also regulated.
Penalties for Non-Compliance and Their Deterrent Effect
The Medicines Act prescribes specific penalties for breaches of its advertising provisions, reflecting the importance of compliance in safeguarding public health.
"50.—(7) Any person guilty of an offence under this section shall be liable on conviction to a fine not exceeding $5,000 or to imprisonment for a term not exceeding 2 years or to both. 51.—(3) Any person who contravenes subsection (1) shall be guilty of an offence and shall be liable on conviction to a fine not exceeding $5,000 or to imprisonment for a term not exceeding 2 years or to both. 53.—(2) Any person who without reasonable excuse fails to comply with any requirement imposed on that person by a notice under this section shall be guilty of an offence and shall be liable on conviction to a fine not exceeding $2,000." — Sections 50(7), 51(3), 53(2), Medicines Act 1975
The penalties for issuing false or misleading advertisements (Section 50) and for prohibited medical advertisements (Section 51) include fines up to $5,000 and imprisonment up to two years, or both. These stringent penalties serve as a strong deterrent against irresponsible advertising practices that could harm consumers. The lower fine for failure to comply with notices to furnish advertisement copies (Section 53) reflects the administrative nature of that offence but still ensures cooperation with regulatory authorities.
Cross-References to Other Provisions and Their Regulatory Significance
The Medicines Act’s advertising provisions are interconnected with other parts of the Act and schedules, ensuring a coherent regulatory regime.
"50.—(2) Where a licence under Part 2 is in force which is applicable to medicinal products of a particular description... (8) In this section “unauthorised recommendations”, in relation to the circumstances specified in subsection (2), means recommendations whereby medicinal products of a description to which the licence in question is applicable are recommended to be used for purposes other than those specified in the licence. 51.—(1)(a) any medical advertisement which directly or indirectly claims, indicates or suggests that the article advertised will prevent, alleviate or cure any disease or condition specified in the First Schedule; (4)(a) The Minister may by order— (a) amend the First Schedule; and (b) exempt any advertisement or class of advertisements from subsection (1)." — Sections 50(2), 50(8), 51(1)(a), 51(4), Medicines Act 1975
Section 50 references Part 2 of the Act, which governs the licensing of medicinal products. This linkage ensures that advertisements are consistent with the licensed indications of medicinal products, preventing off-label promotion that could mislead consumers or pose health risks. Section 51 references the First Schedule, which lists diseases or conditions for which advertisements claiming prevention, alleviation, or cure are prohibited. This linkage allows the Minister to update the list of protected diseases through orders, maintaining regulatory relevance as medical knowledge and public health priorities evolve.
Conclusion
The Medicines Act’s provisions on medical advertisements are carefully crafted to balance the need for public information with the imperative to protect consumers from false, misleading, or harmful claims. By defining key terms broadly, prohibiting unsubstantiated claims especially concerning serious diseases, empowering the Minister to regulate dynamically, and imposing significant penalties for non-compliance, the Act establishes a robust framework that promotes truthful and responsible advertising of medicinal products in Singapore.
Sections Covered in This Analysis
- Section 49 – Definitions of "advertisement," "medical advertisement," and "representation"
- Section 50 – Prohibition of false or misleading advertisements and representations; offences and penalties
- Section 51 – Prohibition of certain medical advertisements relating to diseases in the First Schedule; offences and penalties
- Section 52 – Minister’s power to regulate advertisements by regulations
- Section 53 – Licensing authority’s power to require copies of advertisements; offences and penalties
- Cross-references to Part 2 (licensing) and the First Schedule (list of diseases)
Source Documents
For the authoritative text, consult SSO.